Current and emerging medications for the management of obesity in adults

Joshua M Inglis, Ganessan Kichenadasse and Arduino A Mangoni
Med J Aust 2023; 219 (4): . || doi: 10.5694/mja2.52028
Published online: 21 August 2023

To the Editor: We congratulate Walmsley and Sumithran1 for their excellent review on medications for the management of obesity in adults. We also wish to highlight a safety signal for thyroid cancer with glucagon‐like peptide 1 (GLP‐1) receptor agonists, which is a relevant issue to prescribers given the widespread use of these agents for obesity.

  • 1 Flinders Medical Centre, Adelaide, SA
  • 2 Flinders University, Adelaide, SA
  • 3 University of Adelaide, Adelaide, SA

Competing interests:

No relevant disclosures.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.